Dr. Josep Genebriera De Lamo, M.D.
What this data tells you about Dr. Genebriera De Lamo
Dr. Josep Genebriera De Lamo is a student in an organized health care education/training program in Jacksonville, FL, with 17 years in practice. Based on federal Medicare data, Dr. Genebriera De Lamo performed 12,944 Medicare services across 6,829 unique beneficiaries.
Between the years covered by Open Payments, Dr. Genebriera De Lamo received a total of $175,366 from 44 pharmaceutical and/or device companies across 1485 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Genebriera De Lamo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 | 4,847 | $5 | $25 |
| Office visit, established patient (20-29 min) | 2,209 | $60 | $318 |
| Destruction of precancerous skin growth, 1 | 1,257 | $34 | $245 |
| Skin biopsy, tangential | 1,063 | $63 | $380 |
| Destruction of skin growths (warts/lesions), 1-14 | 802 | $78 | $420 |
| Office visit, established patient (30-39 min) | 730 | $85 | $446 |
| Biopsy of related skin growth, each additional growth | 381 | $39 | $189 |
| Steroid injection (triamcinolone) | 259 | $1 | $4 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 191 | $225 | $1,113 |
| New patient office visit (30-44 min) | 160 | $72 | $393 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 150 | $97 | $891 |
| Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | 120 | $129 | $702 |
| New patient office visit (45-59 min) | 106 | $111 | $582 |
| Destruction of precancer skin growth, 15 or more growths | 86 | $125 | $617 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | 81 | $190 | $978 |
| Drug injection, under skin or into muscle | 79 | $10 | $51 |
| Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | 63 | $67 | $634 |
| Office visit, established patient (10-19 min) | 63 | $40 | $201 |
| Biopsy of ear | 44 | $55 | $355 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 34 | $300 | $1,175 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 33 | $112 | $1,009 |
| Injection into skin growth, 1-7 growths | 30 | $34 | $207 |
| Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | 25 | $60 | $577 |
| Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 23 | $101 | $919 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | 20 | $140 | $756 |
| Application of light to destroy precancer skin growth | 18 | $74 | $551 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | 16 | $188 | $871 |
| Punch biopsy, first skin growth | 14 | $96 | $472 |
| Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | 14 | $238 | $1,139 |
| Application of light with debridement to destroy precancer skin growth | 14 | $218 | $1,074 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 12 | $362 | $1,719 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in student in an organized health care education/training program and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for student in an organized health care education/training program in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Genebriera De Lamo is a clinical cardiology specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (speaking/promotional, top 0%), with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Genebriera De Lamo experienced with destruction of precancerous skin growths, 2-14?
Does Dr. Genebriera De Lamo receive payments from pharmaceutical companies?
How do Dr. Genebriera De Lamo's costs compare to other student in an organized health care education/training programs in Jacksonville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology